CN Patent

CN102076353A — 胰岛淀粉样多肽和鲑鱼降钙素的衍生杂合肽

Assigned to Novo Nordisk AS · Expires 2011-05-25 · 15y expired

What this patent protects

本发明描述了杂合肽衍生物和包含它们的药物组合物，其中所述杂合肽包含人胰岛淀粉样多肽序列的C-末端、鲑鱼降钙素肽序列的中间部分和人胰岛淀粉样多肽序列的N-末端，并且其中白蛋白结合部分与所述杂合肽连接，任选通过接头连接。

USPTO Abstract

本发明描述了杂合肽衍生物和包含它们的药物组合物，其中所述杂合肽包含人胰岛淀粉样多肽序列的C-末端、鲑鱼降钙素肽序列的中间部分和人胰岛淀粉样多肽序列的N-末端，并且其中白蛋白结合部分与所述杂合肽连接，任选通过接头连接。

Drugs covered by this patent

Patent Metadata

Patent number
CN102076353A
Jurisdiction
CN
Classification
—
Expires
2011-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.